• L-Phenylephrine in Sex-Aware Adrenergic Research

  2026-08-19

  L-Phenylephrine offers a focused way to interrogate α1A-linked physiology across cardiovascular, neural, and airway models. When paired with sex-aware experimental design and rigorous exposure controls, it can help connect receptor selectivity with translationally relevant phenotypes.

• Necrosulfonamide Workflows for MLKL Research

  2026-08-19

  Necrosulfonamide provides a pathway-focused way to test whether membrane-disruptive necroptosis is driven by MLKL rather than by apoptosis or nonspecific toxicity. This article translates cardiac ischemia–reperfusion findings into practical assay design for cardiovascular, cancer, and neurodegenerative disease model research.

• Genotyping Kit for Target Alleles: Barrier Research

  2026-08-18

  SKU K1026 streamlines allele screening across insects, tissues, fishes, and cultured cells by combining single-tube DNA preparation with dye-containing PCR. Its practical value is especially clear in mechanistic studies where genotype confirmation must keep pace with tissue phenotyping, barrier assays, and host-microbe experiments.

• ABT-888 (Veliparib) DNA Repair Workflows

  2026-08-18

  ABT-888 (Veliparib) enables controlled PARP1/2 inhibition for DNA damage response studies, combination screening, and colorectal cancer research. This guide translates its preclinical chemo- and radiosensitization profile into practical workflows while emphasizing biomarker selection, assay controls, and context-specific interpretation.

• Proteoform-Specific Drug Interactions in Native Membranes

  2026-08-17

  Lutomski and colleagues developed a native top-down mass spectrometry workflow that releases membrane proteins and signaling complexes directly from retinal disc membranes, preserving links between proteoforms, lipid modifications, and ligand interactions. The study shows how proteoform-resolved analysis can clarify PDE6 off-target binding and improve the interpretation of drug selectivity in native signaling environments.

• Sulfo-Cy3 NHS Ester for Vascular Assays

  2026-08-17

  Sulfo-Cy3 NHS Ester provides a hydrophilic fluorescent dye strategy for studying the AIBP–LRP2–HDL–miR-223–CXCR4 pathway. This article translates the pathway’s mechanistic findings into practical decisions for protein labeling, uptake assays, tissue imaging, and quantitative fluorescence controls.

• Annexin V-Cy5/DAPI Apoptosis Kit Workflow

  2026-08-16

  The Annexin V-Cy5/DAPI Apoptosis Kit converts phosphatidylserine exposure and membrane integrity into a fast, two-parameter cell-death readout. This guide applies the assay to drug-response studies, including the P2RX1–CaMKII–PI3K/Akt mechanism reported in Ph+ ALL, while emphasizing controls, workflow design, and troubleshooting.

• Amikacin Sulfate: From Mechanism to Translation

  2026-08-15

  A translational strategy for using Amikacin Sulfate in intracellular and granuloma-focused NTM research, integrating bacterial killing, cellular uptake, tissue exposure, and functional-selection thinking from Cas9 inhibitor discovery.

• Deferasirox and Lysosomal Iron Stress

  2026-08-14

  Deferasirox is an oral iron chelator with applications extending from iron overload treatment to mechanistic studies of nutrient stress. This article connects its established iron and mitochondrial effects with TCF25-driven lysosomal adaptation while defining practical assay boundaries.

• γH2AX DNA Damage Detection Kit: FLASH-RT

  2026-08-14

  The γH2AX DNA Damage Detection Kit provides a spatial readout of radiation-induced double-strand break signaling. This article explains how to interpret γ-H2AX foci in FLASH-RT and radiosensitizer studies, including the practical limits of using this DNA damage biomarker γ-H2AX as a standalone endpoint.

• EGCG Nanoparticles Enhance FLASH Radiotherapy

  2026-08-13

  Xu and colleagues developed functionalized, self-assembled EGCG nanoparticles as a radiosensitizing strategy for FLASH radiotherapy. Their findings connect enhanced tumor-cell oxidative and DNA damage with apoptosis, tumor control, and activation of antitumor immune responses, while also highlighting the need for careful mechanistic and safety validation.

• Amikacin Sulfate: NTM Assay Workflows

  2026-08-13

  Build more informative NTM experiments with Amikacin Sulfate by pairing extracellular CFU testing with intracellular dendritic-cell assays and tissue-level pharmacology. This workflow also adapts kidney-injury endpoints from nicotine research to improve interpretation of systemic exposure and toxicity.

• PSPro Enables All-at-Once Spatial Proteome Profiling

  2026-08-12

  Mao and colleagues introduce PSPro, a proximity-labeling workflow that captures cell-type-associated proteomes directly from tissue slices without requiring exhaustive cell-by-cell microdissection. Its application to pancreatic tumor and spleen tissue demonstrates broad protein enrichment and reveals spatial heterogeneity among cancer and immune cell populations.

• DNA Frameworks Improve Enzymatic Oligonucleotide Synthesis

  2026-08-12

  The reference study introduces tetrahedral DNA nanostructures as an ordered interface for improving primer presentation during enzymatic oligonucleotide synthesis. By increasing enzyme accessibility and reducing deletion errors, the framework supported a 60-nucleotide information-storage sequence with a reported stepwise yield of 96.82% and accurate recovery of 15 bytes of text.

• Topotecan HCl: Readouts That Reveal Drug Action

  2026-08-11

  Topotecan HCl research becomes more informative when cytotoxicity is separated from proliferative arrest. This guide applies a dissertation-derived viability framework to dose, timing, assay selection, and translational interpretation of topoisomerase 1 inhibitor experiments.

16502 records 1/1101 page Next 12345 下5页 Last page